1. Pharmacokinetics of sunitinib in combination with fluoroquinolones in rabbit model
   Edyta Szałek et al, 2013, Pharmacological Reports CrossRef
2. CYP3A5 rs776746 Genotyping by SYBR Green-Based Real-Time Multiplex Polymerase Chain Reaction Combined with Melting Curve Analysis Using Tm-Shift Method
   Geon Park, 2024, Journal of Laboratory Medicine and Quality Assurance CrossRef
3. Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype
   Yuji Miura et al, 2014, BMC Cancer CrossRef
4. Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo
   Brian Jensen et al, 2017, Metabolites CrossRef
5. Individualized dosing of tyrosine kinase inhibitors: are we there yet?
   Djoeke de Wit et al, 2015, Drug Discovery Today CrossRef
6. Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
   Timothy J. Stuhlmiller et al, 2017, Journal of the American Heart Association CrossRef
7. A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine
   Kotoe Takayoshi et al, 2015, BMC Cancer CrossRef